Skip to main content

Advertisement

Table 1 Demographic and baseline characteristics

From: Vitreous haemorrhage in massive hemorrhagic polypoidal choroidal vasculopathy: clinical characteristics and surgical outcomes

1. No of eyes 28
2. Age (mean) 58.89 years (range 36–82)
3. Gender 22 males, 6 females
4. Bilateral PCV + VH 4 (14.28 %)
5. DM/duration 10 patients/13 years (range 3–25 years)
6. Hypertension/duration 15 patients/10.5 years (range 1–36 years)
7. Eye 13 OD, 15 OS
8. Duration of symptoms in months 6.2 (range 1–48 months)
9. Lens status 11 phakic, 6 pseudophakic, 1 aphakic
10. Previous treatment VR surgery (n = 3), IVB (n = 5), PDT (n = 3), Laser (n = 1), IVTA (n = 1), Oral steroids (n = 3)
11. Fundus exam at presentation No view (n = 21), hemorrhagic PED (n = 6), subretinal blood (n = 4), pigmentary changes (n = 1)
  1. PCV polypoidal choiroidal vasculopathy, VH vitreous hemorrhage, DM diabetes mellitus, VR vitreoretinal, IVB intravitreal bevacizumab, PDT photodynamic therapy, IVTA intravitreal triamcinolone acetonide, PED pigment epithelial detachment